CME is often evaluated by participation rates, satisfaction scores, and knowledge gains. These metrics are important as they demonstrate engagement and exposure. However, they do not necessarily demonstrate change. Across therapeutic areas, clinical variability persists despite widespread dissemination of guidelines and data. The disconnect reveals a fundamental design issue; many programs are built around content
Why CGMs, wearables, digital monitoring tools, and remote platforms remain underused. Address workflow integration, reimbursement complexity, and clinician confidence.
Clinicians are increasingly exposed to RWE, but many lack training in study design interpretation. Break down confounding, selection bias, and applicability to practice.
Analyze how behavioral health, adherence barriers, and social determinants of health remain under-assessed in specialty care despite strong evidence of impact on outcomes.
Address clinician difficulty interpreting biomarker data, device-generated metrics, genomics panels, and real-world evidence.
Explore persistent gaps between evidence-based guidelines and real-world implementation across cardiometabolic disease, oncology, and immunology.
